Table 2.

Results (in terms of ICER) of subgroup analyses

Subgroup	ICER (cost/QALY gained)	% Change from deterministic ICER
T2DM at baseline	£6974	−10%
No T2DM at baseline	£8221	6%
Baseline age <65 years	£6147	−21%
Baseline age ≥65 years	£8772	13%
Baseline eGFR <60 ml/min/1.73 m2	£7905	2%
Baseline eGFR ≥60 ml/min/1.73 m2	£7851	1%

AE, adverse events; CV, cardiovascular; eGFR, estimated glomerular filtration rate; ICER, incremental cost-effectiveness ratio; HF, heart failure; hHF, hospitalization for heart failure; QALY, quality-adjusted life-year; SoC, standard of care; T2DM, type II diabetesmellitus.